Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience☆☆This study was sponsored by Procter & Gamble Pharmaceuticals, Cincinnati, Ohio, and Aventis Pharma, Bridgewater, New Jersey.-Reference-Cited by-同舟云学术

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience☆☆This study was sponsored by Procter & Gamble Pharmaceuticals, Cincinnati, Ohio, and Aventis Pharma, Bridgewater, New Jersey.

Published:2003-02 Issue:2 Volume:32 Page:120-126
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Sorensen O.H,Crawford G.M,Mulder H,Hosking D.J,Gennari C,Mellstrom D,Pack S,Wenderoth D,Cooper C,Reginster J.-Y

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference10 articles.

1. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis; a randomized controlled trial;Harris;J Am Med Assoc,1999

2. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis;Reginster;Osteoporos Int,2000

3. Effect of risedronate on the risk of hip fracture in elderly women;McClung;N Engl J Med,2001

4. Risedronate reduces the risk of first vertebral fracture in osteoporotic women;Heaney;Osteoporos Int,2002

5. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the Fracture Intervention Trial;Cummings;J Am Med Assoc,1998

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Summary of the Thai Osteoporosis Foundation (TOPF) Clinical Practice Guideline on the diagnosis and management of osteoporosis 2021;Osteoporosis and Sarcopenia;2023-06

2. Recommendations for the Pharmacological Treatment of Osteoporosis – Update 2023 of the German Osteoporosis Guideline;Osteologie;2023-05

3. Risk factors for new vertebral compression fracture after kyphoplasty and efficacy of osteoporosis treatment: A STROBE-compliant retrospective study;Medicine;2022-12-09

4. Real-world effectiveness of osteoporosis treatments in Germany;Archives of Osteoporosis;2022-08-31

5. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women;Cochrane Database of Systematic Reviews;2022-05-03